Leicester will join the likes of Copenhagen, Mexico City, Rome and Shanghai in becoming part of the Cities Changing Diabetes programme to tackle the dramatic rise of type 2 diabetes in urban areas.
The Leicester Diabetes Centre, responsible for this unique partnership, is a world-leading clinical research, evidence-based education and cutting-edge innovation. Based at Leicester General Hospital, and serving as a partnership and collaboration between Leicester’s Hospitals and the University of Leicester, it is now Europe’s largest diabetes facility, with strong links to local Clinical Commissioning Groups.
An overwhelming two-thirds of people with diabetes worldwide live in urban areas, complex environments in which a variety of nutritional, demographic, social, cultural and economic factors impact the health of their inhabitants. In the UK, Leicester is home to one of the largest populations of people with diabetes – almost 9% of its residents – well above the national average of 6.4%.
Living with type 2 diabetes can reduce life expectancy by as much as 10 years and can double an individual’s risk of stroke within the first five years of diagnosis compared with the general population. Joining a network of global forerunners to explore ways of encouraging healthy lifestyle habits in cities will help the approximate 26,500 people already living with diabetes in Leicester and thousands more at risk of developing the disease.
To read more about this Global initiative please go to University Hospitals of Leicester (UHL) website: